Study shows white blood cell boosting drugs safe during chemo-radiotherapy of lung cancer

A late breaking sub-analysis of the phase III CONVERT trial presented at the European Lung Cancer Conference shows that white blood cell boosting drugs are safe during concurrent chemo-radiotherapy of small cell lung cancer.
EurekAlert